Performance of continuous controlled attenuation parameter and liver stiffness measurement by the novel SmartExam in metabolic dysfunction-associated steatotic liver disease.
Sherlot J SongAsako NogamiLilian Yan LiangMasato YonedaHoward H W LeungAtsushi NakajimaJimmy Che To LaiGrace Lai-Hung WongSally S T ShuVincent Wai-Sun WongTerry Cheuk Fung YipPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
The SmartExam-based VCTE reduces the variability of CAP measurement and achieves a similar accuracy as the FibroScan 502 device for the estimation of both hepatic steatosis and fibrosis. Future studies should determine if cCAP is a better tool to monitor changes in steatosis than the original CAP.